152 related articles for article (PubMed ID: 12770782)
1. Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
Sadeghlar F; Remmel N; Breiden B; Klingenstein R; Schwarzmann G; Sandhoff K
Biochimie; 2003; 85(3-4):439-48. PubMed ID: 12770782
[TBL] [Abstract][Full Text] [Related]
2. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.
Schmid B; Paton BC; Sandhoff K; Harzer K
Hum Genet; 1992 Jul; 89(5):513-8. PubMed ID: 1634229
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
[TBL] [Abstract][Full Text] [Related]
5. Expression of the three alternative forms of the sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture system.
Henseler M; Klein A; Glombitza GJ; Suziki K; Sandhoff K
J Biol Chem; 1996 Apr; 271(14):8416-23. PubMed ID: 8626540
[TBL] [Abstract][Full Text] [Related]
6. A triple-binding-domain model explains the specificity of the interaction of a sphingolipid activator protein (SAP-1) with sulphatide, GM1-ganglioside and globotriaosylceramide.
Wynn CH
Biochem J; 1986 Dec; 240(3):921-4. PubMed ID: 3827882
[TBL] [Abstract][Full Text] [Related]
7. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
Sandhoff K; Kolter T
Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo.
Klein A; Henseler M; Klein C; Suzuki K; Harzer K; Sandhoff K
Biochem Biophys Res Commun; 1994 May; 200(3):1440-8. PubMed ID: 8185598
[TBL] [Abstract][Full Text] [Related]
9. Intracellular trafficking of glycosphingolipids: role of sphingolipid activator proteins in the topology of endocytosis and lysosomal digestion.
Sandhoff K; Klein A
FEBS Lett; 1994 Jun; 346(1):103-7. PubMed ID: 8206147
[TBL] [Abstract][Full Text] [Related]
10. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis.
Zschoche A; Fürst W; Schwarzmann G; Sanhoff K
Eur J Biochem; 1994 May; 222(1):83-90. PubMed ID: 8200356
[TBL] [Abstract][Full Text] [Related]
11. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.
Bradová V; Smíd F; Ulrich-Bott B; Roggendorf W; Paton BC; Harzer K
Hum Genet; 1993 Sep; 92(2):143-52. PubMed ID: 8370580
[TBL] [Abstract][Full Text] [Related]
12. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide.
Li SC; Kihara H; Serizawa S; Li YT; Fluharty AL; Mayes JS; Shapiro LJ
J Biol Chem; 1985 Feb; 260(3):1867-71. PubMed ID: 2981875
[TBL] [Abstract][Full Text] [Related]
13. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.
Paton BC; Schmid B; Kustermann-Kuhn B; Poulos A; Harzer K
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):481-8. PubMed ID: 1637339
[TBL] [Abstract][Full Text] [Related]
14. A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD).
Wrobe D; Henseler M; Huettler S; Pascual Pascual SI; Chabas A; Sandhoff K
J Inherit Metab Dis; 2000 Feb; 23(1):63-76. PubMed ID: 10682309
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts.
Fujibayashi S; Wenger DA
Biochim Biophys Acta; 1986 Feb; 875(3):554-62. PubMed ID: 3081038
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell.
Sandhoff K; Kolter T; Van Echten-Deckert G
Ann N Y Acad Sci; 1998 Jun; 845():139-51. PubMed ID: 9668348
[TBL] [Abstract][Full Text] [Related]
17. Glycosphingolipid specificity of the human sulfatide activator protein.
Vogel A; Schwarzmann G; Sandhoff K
Eur J Biochem; 1991 Sep; 200(2):591-7. PubMed ID: 1889421
[TBL] [Abstract][Full Text] [Related]
18. Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1).
Inui K; Wenger DA
Arch Biochem Biophys; 1984 Sep; 233(2):556-64. PubMed ID: 6435528
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipid hydrolases and activator proteins.
Bierfreund U; Kolter T; Sandhoff K
Methods Enzymol; 2000; 311():255-76. PubMed ID: 10563332
[No Abstract] [Full Text] [Related]
20. Identity of the activator proteins for the enzymatic hydrolysis of sulfatide, ganglioside GM1, and globotriaosylceramide.
Vogel A; Fürst W; Abo-Hashish MA; Lee-Vaupel M; Conzelmann E; Sandhoff K
Arch Biochem Biophys; 1987 Dec; 259(2):627-38. PubMed ID: 3426245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
